IP Library Granted Patent US 10,150,994
Granted Patent B2
US 10,150,994 · App. 15/215,234 · Granted Dec 11, 2018

Modular flow cells and methods of sequencing

Inventors: Jerzy Olejnik (Brookline, MA); Dirk Zimmermann (Waltham, MA)
Assignees: Qiagen Waltham, Inc.; Qiagen Instruments AG
C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,150,994
App. No.
15/215,234
Granted
Dec 11, 2018
Kind
B2
Abstract

Modular flow cells, devices with modular flow cells, and methods of sequencing using modular flow cells, as well as systems and kits including modular flow cells, are described, permitting sequencing wherein less than the full capacity for sequencing is desired.

Claims (29)

1. A method of incorporating labeled nucleotides into nucleic acid, comprising:

a) providing

i) a modular flow cell comprising a plurality of modules, wherein said modules are moveable and removable inserts, each module comprising biomolecules bound to a surface of a lane or fluidic channel, said plurality of modules sharing an input and output port, wherein each module comprises a fluidic channel and the fluidic channel of one module is blocked so that no solutions enter said blocked fluidic channel,

ii) a first solution comprising polymerase and a plurality of nucleotide analogues wherein at least one nucleotide analogue is labeled with a unique label and contains a removable chemical moiety capping the 3′-OH group, and

iii) a second solution comprising a cleaving agent;

b) introducing said first solution into at least one module of said plurality of modules under conditions wherein a first nucleotide analogue is incorporated by said polymerase;

c) detecting the label of the incorporated nucleotide analogue; and

d) introducing said second solution into said at least one module under conditions such that the chemical moiety of the incorporated nucleotide analogue capping the 3′-OH group is removed by said cleaving agent.

2. The method of claim 1 , wherein the fluidic channel of said one module is blocked with a plug.

3. The method of claim 1 , wherein said biomolecules comprise primers for sequencing.

4. A method of incorporating labeled nucleotides into nucleic acid, comprising:

a) providing

i) a modular flow cell comprising a plurality of modules, wherein said modules are moveable and removable inserts, each module comprising biomolecules bound to a surface of a fluidic channel, each fluidic channel having a separate input and output port, wherein the fluidic channel of one module is blocked so that no solutions enter said blocked fluidic channel,

ii) a first solution comprising polymerase and a plurality of nucleotide analogues wherein at least one nucleotide analogue is labeled with a unique label and contains a removable chemical moiety capping the 3′-OH group, and

iii) a second solution comprising a cleaving agent;

b) introducing said first solution into at least one module of said plurality of modules under conditions wherein a first nucleotide analogue is incorporated by said polymerase;

c) detecting the label of the incorporated nucleotide analogue; and

d) introducing said second solution into said at least one module under conditions such that the chemical moiety of the incorporated nucleotide analogue capping the 3′-OH group is removed by said cleaving agent.

5. The method of claim 4 , wherein the fluidic channel of said one module is blocked with a plug.

6. The method of claim 4 , wherein said biomolecules comprise primers.

7. A method of incorporating labeled nucleotides into nucleic acid, comprising:

a) providing

i) a modular flow cell comprising four modules, wherein said modules are moveable and removable inserts, at least one of which comprise biomolecules bound to a surface of a fluidic channel, wherein one module comprises no biomolecules in the fluidic channel, and no sequencing takes place in that channel;

ii) a first solution comprising polymerase and a plurality of nucleotide analogues wherein each nucleotide analogue is labeled with a unique label and contains a removable chemical moiety capping the 3′-OH group, and

iii) a second solution comprising a cleaving agent;

b) introducing said first solution into said four modules under conditions wherein a first nucleotide analogue is incorporated by said polymerase in at least one of said four modules;

c) detecting the label of the incorporated nucleotide analogue; and

d) introducing said second solution into said at least one module under conditions such that the chemical moiety of the incorporated nucleotide analogue capping the 3′-OH group is removed by said cleaving agent.

8. The method of claim 7 , wherein said biomolecules comprise primers for sequencing.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2019
From: QIAGEN INSTRUMENTS AG
To: QIAGEN GMBH
Reel/Frame 048702/0228 →
MERGER Recorded Nov 16, 2018
From: QIAGEN WALTHAM, INC.
To: QIAGEN SCIENCES, LLC
Reel/Frame 047588/0843 →
MERGER Recorded Nov 8, 2018
From: QIAGEN WALTHAM, INC.
To: QIAGEN SCIENCES, LLC
Reel/Frame 047923/0815 →
CHANGE OF NAME Recorded May 17, 2018
From: INTELLIGENT BIO-SYSTEMS, INC.
To: QIAGEN WALTHAM, INC.
Reel/Frame 047132/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2018
From: ZIMMERMANN, DIRK
To: QIAGEN INSTRUMENTS AG
Reel/Frame 046591/0552 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2018
From: OLEJNIK, JERZY
To: INTELLIGENT BIO-SYSTEMS, INC.
Reel/Frame 044565/0194 →
Continuity (2)
Provisional Application 62195585 · Jul 22, 2015
Related Publication 20170022555A1 · Jan 26, 2017